Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells
Open Access
- 1 December 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (12) , 3829-3835
Abstract
Graft-versus-host disease (GVHD) and failure of engraftment limit clinical bone marrow transplantation (BMT) to patients with closely matched donors. Engraftment failure of purified allogeneic hematopoietic stem cells (HSCs) has been decreased in various BMT models by including donor BM–derived CD8+/αβγδTCR- facilitating cells (FCs) or CD8+/αβTCR+ T cells in the BM inoculum. To aggressively investigate the GVHD potential of these donor CD8+ populations, a purified cell model of lethal GVHD was established in a murine semiallogeneic parent → F1 combination. Lethally irradiated recipients were reconstituted with purified donor HSCs alone or in combination with splenic T cells (TSP), BM-derived T cells (TBM), or the FC population. In marked contrast to the lethal GVHD present in recipients of HSCs plus TSP or CD8+ TBM, recipients of donor HSC+FC inocula did not exhibit significant clinical or histologic evidence of GVHD. Instead, HSC+FC recipients were characterized by increased splenocyte expression of transforming growth factor-β (TGF-β) and the induction of the regulatory T-cell genes CTLA4, GITR, and FoxP3. These findings suggest that the FCs, which express a unique FCp33-TCRβ heterodimer in place of αβTCR, permits HSC alloengraftment and prevents GVHD through the novel approach of regulatory T-cell induction in vivo.Keywords
This publication has 35 references indexed in Scilit:
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- CD4+CD25+ Immunoregulatory T CellsJournal of Experimental Medicine, 2002
- Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow TransplantationJournal of Experimental Medicine, 2002
- Bone marrow CD8 T cells are in a different activation state than those in lymphoid peripheryEuropean Journal of Immunology, 2002
- The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethalityBlood, 2002
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βJournal of Experimental Medicine, 2001
- Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.Journal of Experimental Medicine, 1993
- T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASETransplantation, 1987
- Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.Journal of Experimental Medicine, 1983
- Gastrointestinal graft-versus-host disease in manAmerican Journal of Surgical Pathology, 1979